Cargando…
Erectile Dysfunction Following Intravitreal Bevacizumab
Despite initial concerns regarding systemic complications, the use of intravitreal antivascular endothelial growth factor (anti-VEGF) agents for ocular disease is rapidly expanding worldwide, in terms of both the number of patients injected and its indications. To our knowledge, there are no cases i...
| Autores principales: | , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Medknow Publications
2010
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2934725/ https://www.ncbi.nlm.nih.gov/pubmed/20844689 http://dx.doi.org/10.4103/0974-9233.65497 |